Chemoinformaics analysis of (+)-Isolariciresinol monoglucoside
| Molecular Weight | 522.547 | nRot | 7 |
| Heavy Atom Molecular Weight | 488.275 | nRig | 23 |
| Exact Molecular Weight | 522.21 | nRing | 4 |
| Solubility: LogS | -2.109 | nHRing | 1 |
| Solubility: LogP | 0.161 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 71 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 37 | No. of Aromatic Carbocycles | 2 |
| nHetero | 11 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 34 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 26 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 11 | No. of Arom Bond | 12 |
| nHA | 11 | APOL | 74.913 |
| nHD | 7 | BPOL | 41.053 |
| QED | 0.257 |
| Synth | 4.689 |
| Natural Product Likeliness | 1.795 |
| NR-PPAR-gamma | 0.05 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.005 |
| Pgp-sub | 0.982 |
| HIA | 0.919 |
| CACO-2 | -6.214 |
| MDCK | 0.0000141 |
| BBB | 0.136 |
| PPB | 0.940858 |
| VDSS | 0.431 |
| FU | 0.0896716 |
| CYP1A2-inh | 0.01 |
| CYP1A2-sub | 0.697 |
| CYP2c19-inh | 0.005 |
| CYP2c19-sub | 0.741 |
| CYP2c9-inh | 0.003 |
| CYP2c9-sub | 0.334 |
| CYP2d6-inh | 0.006 |
| CYP2d6-sub | 0.298 |
| CYP3a4-inh | 0.018 |
| CYP3a4-sub | 0.657 |
| CL | 11.295 |
| T12 | 0.844 |
| hERG | 0.275 |
| Ames | 0.081 |
| ROA | 0.068 |
| SkinSen | 0.268 |
| Carcinogencity | 0.021 |
| EI | 0.016 |
| Respiratory | 0.678 |
| NR-Aromatase | 0.872 |
| Antiviral | Yes |
| Prediction | 0.942136 |